THE BRAFF GROUP DIFFERENCE IS OUR MARKET IMMERSION STRATEGY
Behavioral health has quickly become the most sought after sector in health care M&A, with broad-based interest in residential and community based addictions and substance abuse, mental health, intellectual and developmental disabilities, and autism services providers. Read More >
Home Health & Hospice
Home Health & Hospice
For the first time, every segment in home health and hospice – Medicare, Medicaid, and private duty – are pinging at the same time as buyers seek to build diversified post-acute continuums that address emerging alternative payment models.
Now that competitive bid-like pricing has been rolled out nationally, the home medical equipment sector may well be entering a period of sustained stability – a period that may provide buyers with just enough go-forward confidence to begin selectively investing in the space again. Read More >
While Specialty Rx captures the M&A headlines, the demand for traditional Home Infusion Therapy – and its substantially higher margins – far outstrips supply.
Although the M&A market for urgent care has softened a little since 2014 and 2015, the breadth of buyers interested in the space – notably hospitals, physician groups, and insurers that see urgent care as a critical gatekeeping mechanism – remains impressive.
Health Information Technology will be the bridge from fee-for-service to value based care. With the stakes so high, the demand for – and valuation of – companies with technology enabled tools to provide the right care, to the right patient, in the right setting, at the right time is extraordinary – and growing.
As a result of the ACA, more covered beneficiaries have accessed the health care system, stimulating both demand for, and M&A interest in, health care staffing. The looming question? Whether reform initiatives will drive down hospital occupancy rates and blunt the conditions that gave rise to this renaissance of activity.
Given our extensive knowledge of the market forces driving health care M&A, we have been entrusted by providers adjacent to our core to lead their divestiture efforts.
Since the beginning of this year, there are only seven announced transactions in the specialty pharmacy sector. For an industry that is predicted to continue to grow, what gives with the recent slowdown? The Braff [...]
A New Holy Trinity in Health Care M&A is Re-Writing the Doctrine of Consolidation Just when you thought you had this whole health care M&A thing figured out, a new holy trinity in health care M&A [...]
Don't miss your opportunity to schedule a meeting with Pharmacy Services Managing Director Reg Blackburn. He will be in attendance at the upcoming National Association of Specialty Pharmacy Annual Meeting in Washington D.C. from September 18-20. [...]
Join us at the HME News Business Summit September 10-12 in Cleveland. Managing Director Pat Clifford will be in attendance and would welcome the chance to catch up and let me share what's happening in the HME space. HME [...]